Model Medicines

Model Medicines is an AI-first biotechnology company based in San Diego, California, discovering and developing first-in-class small-molecule drugs by targeting fundamental disease mechanisms it calls biological choke points. Its end-to-end GALILEO AI engine spans drug design, target discovery, and preclinical development, supported by specialized models including AmesNet for regulatory-grade toxicology prediction and ChemPrint for chemical property prediction. Lead programs target RdRp Thumb-1 (a conserved allosteric pocket on viral RNA-dependent RNA polymerase) and BRD4, with lead assets MDL-001, a broad-spectrum oral antiviral candidate, and MDL-4102. Surfaced as a portfolio company of 8vc and added to the API Evangelist network. As of this enrichment pass Model Medicines publishes no public API, developer portal, SDK, or documentation surface; its AI platform is used internally for drug discovery.

Model Medicines is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Drug Discovery, Artificial Intelligence, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub
10.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyDrug DiscoveryArtificial IntelligencePharmaceuticalsSmall MoleculesLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 10.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/model-medicines: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Model Medicines Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: model-medicines
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/model-medicines.png
name: Model Medicines
description: Model Medicines is an AI-first biotechnology company based in San Diego, California, discovering and developing
  first-in-class small-molecule drugs by targeting fundamental disease mechanisms it calls biological choke points. Its end-to-end
  GALILEO AI engine spans drug design, target discovery, and preclinical development, supported by specialized models including
  AmesNet for regulatory-grade toxicology prediction and ChemPrint for chemical property prediction. Lead programs target
  RdRp Thumb-1 (a conserved allosteric pocket on viral RNA-dependent RNA polymerase) and BRD4, with lead assets MDL-001, a
  broad-spectrum oral antiviral candidate, and MDL-4102. Surfaced as a portfolio company of 8vc and added to the API Evangelist
  network. As of this enrichment pass Model Medicines publishes no public API, developer portal, SDK, or documentation surface;
  its AI platform is used internally for drug discovery.
url: https://raw.githubusercontent.com/api-evangelist/model-medicines/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- 8vc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Drug Discovery
- Artificial Intelligence
- Pharmaceuticals
- Small Molecules
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/model-medicines-domain-security.yml
- type: Website
  url: https://modelmedicines.com
- type: PrivacyPolicy
  url: https://modelmedicines.com/privacy-policy
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1